Assessment of erythrocyte SOD activity in different stages of Essential Hypertension patients

Oxidative stress has been found to be associated with most of the diseases. In the past several years, much interest has arisen over the involvement of free radical metabolism in the disturbance in endothelial or intimal cells of blood vessels, which play an important role in the pathogenesis of essential hypertension (HT). Although limited information is available on the activity of antioxidant enzyme erythrocyte superoxide dismutase (SOD) and its relation with blood pressure in patients with HT, alteration in their activity with severity of disease is still obscure. The objective of present study was to estimate the activity of SOD in hypertensive subjects and to determine the variation in erythrocyte SOD activity with increasing blood pressure. In the present study, erythrocyte SOD activity was measured in 90 hypertensive subjects (30-60 years) which were categorized into three groups as pre-hypertension, stage I HT and stage II HT (depending upon their blood pressure) and statistically compared it with that of 30 healthy individuals, served as control. Erythrocyte SOD activity was found to be significantly low in each patient group as compared to control (P<0.001). These activities were also low among three groups of essential hypertension. These findings suggest that depletion in erythrocyte SOD activity with subsequent rise in blood pressure is due to its superoxide anion scavenging action against hypertension induced production of free radical in the body. Thus, erythrocyte SOD activity may be an effective marker of oxidative stress in different stages of essential hypertension and its related complications

Optical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder

Irreversible disability in multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) is largely attributed to neuronal and axonal degeneration, which, along with inflammation, is one of the major pathological hallmarks of these diseases. Optical coherence tomography (OCT) is a non-invasive imaging tool that has been used in MS, NMOSD, and other diseases to quantify damage to the retina, including the ganglion cells and their axons. The fact that these are the only unmyelinated axons within the central nervous system (CNS) renders the afferent visual pathway an ideal model for studying axonal and neuronal degeneration in neurodegenerative diseases. Structural magnetic resonance imaging (MRI) can be used to obtain anatomical information about the CNS and to quantify evolving pathology in MS and NMOSD, both globally and in specific regions of the visual pathway including the optic nerve, optic radiations and visual cortex. Therefore, correlations between brain or optic nerve abnormalities on MRI, and retinal pathology using OCT, may shed light on how damage to one part of the CNS can affect others. In addition, these imaging techniques can help identify important differences between MS and NMOSD such as disease-specific damage to the visual pathway, trans-synaptic degeneration, or pathological changes independent of the underlying disease process. This review focuses on the current knowledge of the role of the visual pathway using OCT and MRI in patients with MS and NMOSD. Emphasis is placed on studies that employ both MRI and OCT to investigate damage to the visual system in these diseases

Not Available

Not AvailableNot AvailableNot Availabl

5-(1-Aryl-3-(thiophen-2-yl)-1H-pyrazol-4-yl)-1H-tetrazoles: Synthesis, structural characterization, Hirshfeld analysis, anti-inflammatory and anti-bacterial studies

A series of novel 5-(1-aryl-3-(thiophen-2-yl)-1H-pyrazol-4-yl)-1H-tetrazoles 7(h-s) were designed and synthesized. Structural characterization was done by spectral and single crystal X-ray studies. The intermolecular interactions of compound 7n were quantified and visualized using Hirshfeld surface analysis. Structures of newly synthesized compounds were docked into active site of COX-2 enzyme PDB: 1CX2, 3.0 Å X-ray resolution and plausible binding modes were compared with standard drug Celecoxib. The results of molecular docking prompted the pharmacological studies for further optimization of identified selective inhibition. The compounds 7k, 7m, 7n, and 7q-s have shown excellent anti-inflammatory activity and compounds 7i, 7k, 7l, 7n, and 7s have exhibited anti-bacterial inhibitory potency in enzyme based assays